The mechanisms by which NAFLD contributes to IR are as follows: (1) Adipose tissue dysfunction and inflammation promote the secretion of adipokines, increase the secretion of pro-inflammatory factors (such as tumor necrosis factor-α), and increase the release of free fatty acids, resulting in decreased insulin sensitivity. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.